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Lysosomes prepared from rat liver and kidney after loading with the detergent Triton WR-1339 show mem- 
brane-bound S-deiodinase activity with marked specificity for 3,3’,5’-triiodothyronine (reverse T3), lesser 
activity with respect o thyroxine (T4) and almost none towards 3,3’,5triiodothyronine (T3). The enzyme 
is thioi dependent and shows maximal catalysis at pH 7.2. As many of the states known to alter thyroid 
hormone levels also affect lysosomal function, inhibition of the lysosomal Y-deiodinase leading to an in- 
crease in intracellular reverse T3 may be an initiating mechanism for thyroid hormone change. 
Lysosome Deiodination Iodothyronine 
1. INTRODUCTION 
In the low T3 syndrome, the thyroid hormone 
changes of lowered T3 and raised rT3 may be a 
homeostatic response to stress states in, for exam- 
ple, starvation, illness, and surgery, but the func- 
tion of these changes is unknown. Further, the 
subcellular site(s) and control mechanism(s) for the 
5 ‘-deiodinase enzymes are controversial. In rats, 
5 ’ -deiodinase activity has been localised in the 
kidney to plasma membrane (PM) [I], and in the 
liver either to the endoplasmic reticulum alone 
(ER) [2,3] or to both the ER and PM [4]. 
In our studies of the intracellular sites for 
5 ’ -deiodination of thyroid hormones, we noted 
substantial 5 ’ -deiodinase activity in the crude 
mitochondrial fraction which includes lysosomes. 
We therefore separated lysosomes from mitochon- 
dria and peroxisomes [5,6] and tested them for 
5 ’ -deiodinase activity. 
2. MATERIALS AND METHODS 
Protein determinations [7] were made in 
duplicate using bovine serum albumin (Sigma) as 
Part of this investigation was presented to the 1984 an- 
nuai meeting of the Endocrine Society of Australia 
Detergent Dithiothreitol Membrane 
standard. Marker enzymes were determined in 
duplicate as follows: Glucose-6-phosphatase (EC 
3.1.3.9) and 5’-nucleotidase (EC 3.1.3.5) were 
assayed [8] and liberated phosphate measured [9]. 
Succinic dehydrogenase (EC 1.3.99.1) was assayed 
by combining 0.1 ml of cell fraction with 0.5 ml of 
0.2 M NazHP04 (pH 7.4), plus 0.3 ml of 0.2 M 
sodium succinate (pH 7.4), plus 0.1 ml of 1% 
(w/v) 3-(4,5-dimethylthiazole)-2$diphenyltetra- 
zolium bromide (MTT, Sigma). Following incuba- 
tion at 37°C for 15 min, the reaction was stopped 
by the addition of 1 ml of 7% (w/v) trichloroacetic 
acid and the colour extracted into 4 ml tetrahydro- 
furan then read at 550 nm. ,&Glucuronidase (EC 
3.2.1.3 1) was assayed using p-nitrophenol glucu- 
ronide (Calbiochem) [IO]. N-Acetyl-&glucosami- 
nidase was assayed fl 1] using 4-methylumbellifer- 
one derivative (Boehringer). 
Lysosomes (‘tritosomes’) were isolated from rat 
livers [5,6] after the prior daily intra-peritoneal in- 
jection of Triton WR-1339 (50 mg/lOO g) for 4 
days, with the following modifications. A tissue 
press (Harvard) was used initially followed by 8 
passes in a hand-held glass Dounce homogeniser, 
the homogenising buffer was expanded to contain 
sucrose, Tris-HCl, KCl, EDTA, dithiothreitol 
(DTT), chloroquine, 250 : 25 : 100 : 15 : 1: 0.02 mM 
(pH 7.4). The need for a thiol cofactor was tested 
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by omitting DTT from the homogenising buffer. 
Tritosomal membranes were fractionated by 1: 6 
dilution of tritosomes with 25 mM Tris-HCl (pH 
7.2) followed by immersion in liquid nitrogen and 
then rapid thawing by shaking at 37°C to lyse the 
membranes. After thawing, the tritosomes were 
brought to 4°C (for all succeeding operations) and 
centrifuged at 260000 x g (Beckman 70 Ti rotor) 
for 30 min and the supernatant decanted. The sedi- 
ment was resuspended in 30 ml of 1.0 M KC1 for 
30 min and centrifuged and decanted as above. 
The remaining sediment was resuspended in 3 .O ml 
of 0.1% (v/v) Triton X-100 for 30 min and then 
diluted to 0.01% and again centrifuged and 
decanted as above. Each of the 3 supernatants and 
the final sediment were assayed (after storage for 
up to 14 days at - 20°C) for both rT3 5 ’ -deiodi- 
nase and N-acetyl-,8-glucosaminidase in 0.01% 
(v/v) Triton X-100. 
Enriched PM fractions were prepared from the 
livers of 200-g male rats [12]. The method was ex- 
tended by retaining the upper layer after sedimen- 
tation of PM at 7000 x g. This latter layer was 
diluted to 250 nM sucrose and a crude mitochon- 
drial fraction (12000 x g for 30 min) was 
sedimented. The supernatant was then centrifuged 
at 260000 x g for 60 min to give an enriched ER 
fraction. 
Outer ring (5 ’ -) deiodination by fractions at pH 
7.2 containing DTT was semi-quantitatively 
estimated in duplicate by measuring [ 131 the en- 
zymic release of ‘*‘I- from the following 
iodothyronines labelled in the outer ring (final 
assay concentrations in parentheses): T4 (100 nM), 
T3 (10 nM) and rT3 (10 nM). Radioisotopes were 
products of New England Nuclear. HPLC was 
used to separate and identify iodothyronines [13] 
modified to use 3’-isopropyl-3,5-diiodothyronine 
(a gift of the late Professor Jorgensen) as an inter- 
nal standard. This iodothyronine migrates between 
rT3 and T4 in the chromatogram. Determinations 
of 1251- (by ion exchange) and then of 
iodothyronines (by HPLC) can be made on the 
same sample. 
Quantitative kinetic analysis of 5 ’ -deiodinase 
activities in cell fractions using the above tech- 
niques was done by warming a sample of enzyme 
at 37°C for 5 min and then adding to a variable 
substrate concentration spiked with a known quan- 
tity of tracer. The final concentration of DTT was 
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10 mM. At varying intervals (O-20 min) for rT3 
and (O-60 min) for T3 and T4, duplicate samples 
of 0.5 ml were removed and the reaction stopped 
by addition to 0.5 ml of 7% (w/v) trichloroacetic 
acid. Initial velocities were determined by drawing 
tangents to the curves at the origin. Apparent max- 
imum velocities (V,,,) and Michaelis constants 
(K,,,) were then determined [ 141. 
3. RESULTS 
Crude mitochondrial fractions and the subse- 
quently isolated tritosomes (fig. 1) exhibited both 
elevated lysosomal marker enzymes ,8-glucuroni- 
dase and iV-acetyl-,&glucosaminidase and elevated 
rT3 5 ’ -deiodinase with lesser levels of T4 5 ’ -deio- 
dinase. Similar results (not shown) were obtained 
for kidney tritosomes but protein yields were much 
less. 
Variation in DTT concentration showed an 
obligatory requirement of the rT3 5 ’ -deiodinase 
for DTT with maximal activity at approx. 10 mM 
for tritosomes from both liver and kidney. 
The effect of pH on liver tritosomes was exa- 
mined using phosphate, Tris and Hepes buffers. 
Reverse T3 5 ’ -deiodinase has a sharp maximum at 
pH 7.2 in all 3 buffers. T4 5 ’ -deiodinase has a 
broader maximum. 
Fractionation of tritosomal membranes (table 1) 
showed that the rT3 5 ’ -deiodinase enzyme is par- 
ticulate and present as an integral protein in the 
lysosomal membrane requiring the use of Triton 
X-100 to be solubilised. 
Analysis of the tritosomal rT3 deiodinase reac- 
tion, using parallel measurement of I*% and 
iodothyronines indicated that I- and 3,3 ’ -T2 were, 
within the limits of the assay, formed in equimolar 
amounts. Similar analysis using T4 was not possi- 
ble because of insufficient deiodination for 
analysis by HPLC. 
Although concentrations of T4 (100 nM), T3 
(10 nM) and rT3 (10 nM) and the time of incuba- 
tion were selected to assess physiologically relevant 
5 ’ -deiodinase activity in the various subcellular 
fractions, such conditions give neither maximal 
velocities, nor linear velocities during incubation 
and are at best only semi-quantitative. Quan- 
titative kinetic analysis of 5 ’ -deiodination was 
made for T4, T3 and rT3 in the presence of 
saturating concentrations of DTT (10 mM) using 
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Fig, 1. Marker enzyme and 5 ‘-deiodinase activities were determined in liver cell fractions after prior injection of Triton 
WR-1339 [5]. The crude mitochondrial fraction (M+ L) was further separated into lysosomal (tritosomal) and 
mitochondrial fractions [6]. The latter data are shown in the separate segment on the right-hand side of each panel. 
The data are expressed as specific activity relative to homogenate (ordinate) against percent of total protein in each 
fraction (abscissa). N, nuclei/plasma membrane fraction; M, mitochondria; L, lysosomes; P, microsomes; S, cytosol. 
Table 1 
Membrane localisation of tritosomal rT3 5 ’ -deiodinase 
Fraction rT3 5 ’ -deiodinase 
Liver Kidney 
N-Acetyl-,&glucosaminidase 
Liver Kidney 
Tritosomes 100 100 100 100 
Tritosomes after freeze-thawing 135 117 108 128 
Freeze-thawed supernatant 1 10 7 60 43 
KC1 supernatant 2 6 19 23 23 
Triton X-100 supernatant 3 41 84 6 16 
Triton X-100 sediment 14 13 2 10 
Tritosomal membranes were fractionated as described in section 2. Triton X-100 0.1% (v/v) was added to each fraction 
to solubilise membranes but diluted to 0.01% (v/v) for assay. Enzyme activities are expressed as a mean percentage 
of the total value for freshly prepared tritosomes 
223 
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Table 2 
Kinetic parameters for iodothyronine 5’-deiodinase of fractions, from rat liver 
November 1984 
Parameter Substrate Tritosomes Enriched 
plasma 
membranes 
Enriched 
endoplasma 
reticulum 
Michaelis constant 
(Km) O1M) 
M~imum velocity 
(&xl,,) 
(pmol/min per mg) 
rT3 0.53 0.22 0.57 
T4 0.50 0.24 1.90 
rT3 209 42 313 
T4 56 8 38 
Cell fractions were prepared and their 5 ’ -deiodinase activities determined as described in section 2 in the 
presence of 0.01% (v/v) Triton X-100 
tritosomes (table 2) and for comparison, enriched 
liver PM and ER from matched rats not injected 
with Triton WR-1339. Deiodination of T3 was not 
detectable with any fraction. Table 2 shows that 
there is a very active rT3 5 ’ -deiodinase and a less 
active T4 5 ’ -deiodinase in both the tritosomal and 
ER fractions, with much less activity in the PM 
fraction. 
The PM and ER fractions derived from the same 
homogenate show good separation of the marker 
enzymes 5 ’ -nucleotidase (PM) and glucose&phos- 
phatase (ER). When assayed in the absence of 
Triton X-100 both fractions show T4 5’-deiodi- 
nase activity with PM being more active (fig.2). 
Thus both the degree of solubilisation and the 
Protein 5’-NW. GIG T4 
B-Phos. S-Deiod. 
Fig.2. Comparison of marker enzymes from enriched 
plasma membrane (open bars) and enriched endoplasmic 
reticulum fractions (closed bars). The enriched fractions 
were prepared from rat liver by modifying [12] (see 
section 2). 5 ’ -NW., 5 ’ nucleotidase; Glc 6-phos., 
glucose &phosphate; T4 5 ’ -deiod., T4 5 ’ -deiodinase. 
presence of detergent is important in determining 
the apparent rates of reaction, 
4. DISCUSSION 
The ceil fractionation data suggest hat little or 
no 5 ’ -deiodinase was associated with mitochon- 
dria as such. Rather, the concurrence of lysosomal 
marker enzymes with rT3 5 ’ -deiodinase activity in 
tritosomes together with its tight membrane bind- 
ing suggests very strongly that the enzyme is an in- 
tegral part of the lysosome. Although the majority 
of lysosomal enzymes are soluble and occur in the 
matrix, a number have been shown to occur as part 
of the lysosomal membrane [15,16]. The tightly 
bound membrane site for rT3 5 ’ -deiodinase im- 
plies that it is not the source of the soluble 
5 ’ -deiodinase which has been found in variable 
yield in the cytosol by [ 13,171. To improve the 
separation of unbroken tritosomes, chloroquine 
was added to the homogenising buffer [18]. 
Whilst the level of 5 ‘-nucleotidase in the 
tritosomes might be thought to suggest a plasma 
membrane contamination, this does not appear to 
be likely for three reasons: (a) the most highly 
purified preparation of lysosomes yet reported 
show significant enrichment of 5 ’ -nucleotidase 
[ 191, suggesting that it has a dual lysosomal and 
PM location; (b) the specific activity of the PM 
5 ‘-deiodinase is less than that of the tritosomes 
suggesting that membrane traffic from PM to 
lysosome is not the explanation; (c) the fractiona- 
tion studies in which the tritosomai 5 ’ -deiodinase 
activity could not be removed by freeze-thawing or 
224 
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by strong salt solution suggest hat it is indeed an 
integral protein of the lysosomal membrane. 
A definite lysosomal 5 ’ -deiodinase enzyme ac- 
tivity has not previously been demonstrated. It has 
been suggested [2] that tritosomes may possess a 
5 ’ -deiodinase. However, the substrate used was T4 
and not rT3, thus the presence of a highly active 
rT3 5 ’ -deiodinase remained undetected. Here, it is 
evident that the lysosoma15 ’ -deiodinase activity is 
much more specific for rT3 than for T4, with vir- 
tually no activity towards T3. It is similar to other 
described 5 ‘-deiodinases (review [ZO]) in having a 
near to neutral pH optimum at 7.2 and requiring 
a thiol cofactor. 
The analysis of enzyme kinetics is based on the 
assumption that both the enzyme and reactants are 
in true solution. This is clearly not so for par- 
ticulate enzymes and probably not so for 
substrates, such as thyroid hormones, which are 
poorly water soluble and thus usually protein 
bound in aqueous solutions. For a more valid com- 
parison of the particulate deiodinase nzymes from 
various subcellular sites, they were initially 
solubilised in Triton X-100 followed by dilution to 
reduce any inhibitory action of this detergent. In 
fact, solubilisation appears to increase markedly 
the 5 ’ -deiodinase activity of the ER relative to the 
PM fraction when compared to the assay of the 
particulate enzymes without Triton X-100. Laten- 
/ 
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Fig.3. A model for the lysosomal control of 
triiodothyronine metabolism. The model shows the 
factors which could potentially alter the catalytic rate of 
lysosomal rT3 5’-deiodinase and hence alter the 
intracellular pool of rT3. As the concentration of rT3 
varies, it will in turn lead to a varying inhibition of the 
enzymic production of T3 from T4 within the cell. 
cy of membranous enzymes is well known is]. 
Thus both the degree of solubilisation and the 
presence of detergent are important in determining 
apparent rates of reaction. 
The finding of a highly specific lysosomal rT3 
5 ’ -deiodinase suggests a new model for the control 
of iodothyronine metabolism. This model (fig.3) 
suggests that inhibition of the Iysosomal 
5 ’ -deiodinase, for example, by the fall in in- 
tralysosomal pH during autophagy, will lead to an 
increase in the intraceilular concentration of rT3 
which in turn will inhibit the production of T3 
from T4 which has been shown in vitro by [21]. 
The model leads to the following predictions. 
(i) Reverse T3 levels will change prior to changes 
in T3 levels. This was observed in vivo [22,23] in 
thyroide~tomised and normal people respectively. 
(ii) In the low T3, elevated rT3 state (‘low T3 syn- 
drome’), a decrease in the rate of breakdown of 
rT3 and a decrease in the rate of synthesis of T3 
will occur. This is in good agreement with various 
kinetic studies performed in man during the low T3 
syndrome (review [ZO]). 
(iii) A number of drugs known to induce the low 
T3 syndrome may do so in part by their 
lysosomotrophic action, for example dex- 
amethasone, propranolol and salicylate which are 
known to stabilise the lysosomal membrane 1241. 
Thus the model leads to a number of testable 
predictions regarding lysosomal function and 
thyroid hormone metabolism. 
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